16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

20-Nov-15 China’s first listed psychiatric hospital is on track to break the mental-health taboo in a country where such illnesses are still stigmatised by traditional perceptions. Due to begin trading on 27-Nov-15, privately-owned Wenzhou Kangning Hospital is set to raise HKD681 million in a Hong Kong IPO. [image: SCMP / Bruce Yan]

12-Nov-15 Myanmar's public hospitals are now permitted to procure pharmaceuticals through a tender system. In 2014, the volume of drugs available at public hospitals was 35 times higher than in 2011. The tender system is expected to reduce the surpluses and shortages that were common under the former rationing system. [image: Taipei Times]

12-Nov-15 One of the largest and first-of-its kind studies to assess ‘What Ails India’ has found that fever is the most common reason for patients to visit doctors. The study, based on analyses of 554,146 ailments reported in 204,912 patient visits has also revealed that hypertension is the most common diagnosis reported by physicians in India. [image: The Indian Express]

12-Nov-15 Doctors in satellite hospitals in South Vietnam have applied advanced medical techniques transferred from 'core' hospitals, enabling an increase in the number of patients being treated at satellite hospitals. Fourteen central hospitals have been chosen by the Ministry of Health as ‘core' hospitals responsible for transferring advanced medical techniques to 46 satellite hospitals across 38 provinces and cities. [image: Doan Tung]